← Open Payments lookup

SUSAN WALLACE: Open Payments

NPI 1740537687 · HATTIESBURG, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,566 in 126 payments from 18 companies in 2025. Trend: 2023 $1,483 · 2024 $3,163 · 2025 $2,566

Food & beverage: $2,481Education: $85
CompanyPaymentsAmount
ABBVIE INC.50$813
Aimmune Therapeutics, Inc.16$318
Madrigal Pharmaceuticals9$263
Takeda Pharmaceuticals U.S.A., Inc.9$202
Janssen Biotech, Inc.6$189
Regeneron Healthcare Solutions, Inc.5$161
QOL Medical, LLC6$107
Novo Nordisk Inc3$96
Ardelyx, Inc.4$88
Lilly USA, LLC5$82

Products named: RINVOQ, ZENPEP, REZDIFFRA, LINZESS, DUPIXENT, TREMFYA, MAVYRET, Sucraid.

Industry payments across MS — which companies pay providers there.